Arthneeti

Innovassynth Technologies (India) Q1 FY27 Share Price & Earnings Call Analysis

₹151.85-1.97% today
Market cap
₹1,410 Cr
ROE
-25.74%
Price to sales
9.66
Debt to equity
1.19
52W high / low
₹180 / ₹45.0
EBITDA margin
4.16%
Net profit margin
-27.37%
Promoter holding
75.04%
Sales (last year)
₹146 Cr

Incorporated in 2008, Innovassynth Technologies Ltd is a Contract Research, Development and Manufacturing Organization (CRDMO) specializing in pharmaceutical intermediates, oligonucleotide building blocks and specialty chemicals.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Innovassynth Technologies rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Innovassynth Technologies.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Innovassynth Technologies

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Innovassynth Technologies

Quarterly Results

Quarter-by-quarter operating performance

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses +1.184.210.084.991.203.750.095.775.620.130.096.894.61
Operating Profit-1.18-4.21-0.08-4.99-1.20-3.75-0.09-5.77-5.62-0.13-0.09-6.89-4.61
OPM %
Other Income +0.000.004.380.000.000.009.520.00-0.283.434.180.00-0.21
Interest0.080.080.080.080.090.090.120.090.100.110.110.110.12
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-1.26-4.294.22-5.07-1.29-3.849.31-5.86-6.003.193.98-7.00-4.94
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-1.26-4.294.22-5.07-1.29-3.849.31-5.86-6.003.193.98-7.00-4.94
EPS in Rs-0.42-1.431.41-1.70-0.43-1.283.11-1.96-1.740.931.16-2.03-1.44

Financials of Innovassynth Technologies

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +0.000.000.000.000.000.00
Expenses +0.280.371.300.503.9611.72
Operating Profit-0.28-0.37-1.30-0.50-3.96-11.72
OPM %
Other Income +0.001.860.020.00-0.337.40
Interest0.240.270.300.340.400.45
Depreciation0.000.000.000.000.000.00
Profit before tax-0.521.22-1.58-0.84-4.69-4.77
Tax %0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.521.22-1.58-0.84-4.69-4.77
EPS in Rs-0.170.41-0.53-0.28-1.36-1.38
Dividend Payout %0.00%0.00%0.00%0.00%0.00%

Financials of Innovassynth Technologies

Balance Sheet

Capital structure and asset base

Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital24.2824.2824.2827.9827.98
Reserves12.6812.6411.7914.262.32
Borrowings +2.853.243.594.404.86
Other Liabilities +0.941.221.561.962.20
Total Liabilities40.7541.3841.2248.6037.36
Fixed Assets +0.000.000.000.000.00
CWIP0.000.000.000.000.00
Investments40.7441.3541.2148.5337.28
Other Assets +0.010.030.010.070.08
Total Assets40.7541.3841.2248.6037.36

Financials of Innovassynth Technologies

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +-0.32-0.34-0.33-0.73
Cash from Investing Activity +0.000.000.000.00
Cash from Financing Activity +0.320.360.320.77
Net Cash Flow0.000.02-0.010.04
Free Cash Flow-0.32-0.34-0.33-0.73
CFO/OP86%26%66%18%

Financials of Innovassynth Technologies

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %-3.20%-1.25%-9.18%
93out of 100

Momentum score · price trend

93 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+80.2%92%
Last 6 months+138.1%98%
Last 3 months+14.0%86%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Innovassynth Technologies: 0.4 × 92 + 0.4 × 98 + 0.2 × 86 = 93.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Innovassynth Technologies's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF